Patents by Inventor Francois Navarro

Francois Navarro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Macrolides
    Patent number: 7741338
    Abstract: The invention relates to the stabilization of poly-ene macrolides and to a particular macrolide obtained in crystalline form.
    Type: Grant
    Filed: July 6, 2009
    Date of Patent: June 22, 2010
    Assignee: Novartis AG
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • MACROLIDES
    Publication number: 20090270441
    Abstract: The invention relates to the stabilization of poly-ene macrolides and to a particular macrolide obtained in crystalline form.
    Type: Application
    Filed: July 6, 2009
    Publication date: October 29, 2009
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Patent number: 7572804
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2,6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: August 11, 2009
    Assignee: Novartis AG
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Publication number: 20080161334
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2,6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Application
    Filed: October 11, 2007
    Publication date: July 3, 2008
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Patent number: 7297703
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: November 20, 2007
    Assignee: Novartis AG
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Publication number: 20050107418
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Application
    Filed: December 23, 2004
    Publication date: May 19, 2005
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Patent number: 6852729
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: February 8, 2005
    Assignee: Novartis AG
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Publication number: 20030191148
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2, 6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Application
    Filed: March 21, 2003
    Publication date: October 9, 2003
    Inventors: Francois Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Patent number: 6605613
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2,6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: August 12, 2003
    Assignee: Novartis AG
    Inventors: François Navarro, Samuel Petit, Guy Stone
  • Macrolides
    Publication number: 20020032213
    Abstract: A mixture comprising a poly-ene macrolide and an antioxidant. Preferably, the poly-ene macrolide is rapamycin and the antioxidant is 2,6-di-tert.-butyl-4-methylphenol. The presence of the antioxidant improves the stability of the poly-ene macrolide to oxidation.
    Type: Application
    Filed: May 29, 2001
    Publication date: March 14, 2002
    Inventors: Francois Navarro, Samuel Petit, Guy Stone